Immune checkpoint gene signature assesses immune infiltration profiles in bladder cancer and identifies KRT23 as an immunotherapeutic target. Chen D, Cao H, Zheng X, Wang H, et al. BMC Cancer 2024;24:1024.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen D, Cao H, Zheng X, Wang H, et al. Immune checkpoint gene signature assesses immune infiltration profiles in bladder cancer and identifies KRT23 as an immunotherapeutic target. BMC Cancer 2024;24:1024.
PMID: 39160525